 |
Leflunomide |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of acute and chronic rejection in patients who have received solid organ transplants |
| USA Market Approval | USA |
| USA Designation Date | 1996-10-18 00:00:00 |
| Sponsor | Williams, MD, James W.;Rush-Presbyterian-St. Luke's Medical Ctr., Dept. o, 1653 West Congress Parkway;Chicago, Illinois, 60612 |
